Ultrasound in Medicine and Biology
Volume 33, Issue 8 , Pages 1184-1190 , August 2007

QUS in Monitoring Raloxifene and Estrogen-Progestogens: A 4-Year Longitudinal Study

  • D. Agostinelli

      Affiliations

    • Presidio Ospedaliero di Terlizzi, Unità Operativa di Ginecologia e Ostetricia, Ambulatorio per la Menopausa, Terlizzi, Bari, Italy
    • ,
  • F. de Terlizzi

      Affiliations

    • IGEA s.r.l., Technology for Clinical Biophysics, Carpi, Italy
    • Corresponding Author InformationAddress correspondence to: Francesca de Terlizzi, IGEA s.r.l., Via Parmenide 10/A, 41012 Carpi, Mo, Italy.

Received 30 August 2006 ,Revised 12 February 2007 ,Accepted 27 February 2007.

References 

  1. Clowes JA, Peel NF, Eastell R. The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. J Clin Endocrinol Metab. 2004;89(3):1117–1123
  2. Consensus Development Conference. Prophylaxis and treatment of osteoporosis. Am J Med. 1993;94:646–650
  3. Gennazzani AR, Gambacciani M, Schneider HPG, Christiansen C, et al. Postmenopausal osteoporosis: Therapeutics options. Climateric. 2005;8:99–109
  4. Gluer CC. Sense and sensitivity: Monitoring skeletal changes by radiological techniques. J Bone Miner Res. 1999;14:1952–1962
  5. Gonnelli S, Cepollaro C, Pondrelli C, Martini S, Rossi S, Gennari C. Ultrasound parameters in osteoporotic patients treated with salmon calcitonin: A longitudinal study. Osteoporos Int. 1996;6:303–307
  6. Gonnelli S, Cepollaro C. The use of ultrasound in the assessment of bone status. J Endocrinol Invest. 2002;25:389–397
  7. Ingle BM, Machado ABC, Pereda CA, Eastell R. Monitoring alendronate and oestradiol therapy with quantitative ultrasound and bone mineral density. J Clin Densitom. 2005;8:278–286
  8. Krieg MA, Jacquet AF, Bremgartner M, Cuttelod S, Thiebaud D, Burckhardt P. Effect of supplementation with vitamin D3 and calcium on quantitative ultrasound of bone in elderly institutionalized women: A longitudinal study. Osteoporos Int. 1999;9:483–488
  9. Lange U, Illgner U, Teichmann J, Schleenbecker H. Skeletal benefit after one year of risedronate therapy in patients with rheumatoid arthritis and glucocorticoid-induced osteoporosis: A prospective study. Int J Clin Pharmacol Res. 2004;24(2–3):33–38
  10. Mauloni M, Rovati LC, Cadossi R, de Terlizzi F, Ventura V, de Aloysio D. Monitoring bone effect of transdermal hormone replacement therapy by ultrasound investigation at the phalanx: A four year follow-up study. Menopause. 2000;7:402–412
  11. Mele R, Masci G, Ventura V, de Aloysio D, Bicocchi M, Cadossi R. Three-year longitudinal study with quantitative ultrasound at the hand phalanx in a female population. Osteoporosis Int. 1997;7:550–557
  12. Noteloviz M. Osteoporosis: Screening, prevention and management. Fertil Steril. 1993;59:707–725
  13. Sakata S, Barkmann R, Lochmuller EM, Heller M, Gluer CC. Assessing bone status beyond bone mineral density: Evaluation of bone geometry and porosity by quantitative ultrasound of human finger phalanges. J Bone Miner Res. 2004;19:924–930
  14. WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series. 1994;843
  15. Wüster C, Albanese C, de Aloysio D, Duboeuf F, et al. Phalangeal osteosonogrammetry study (PhOS): Age related changes, diagnostic sensitivity and discrimination power. J Bone Miner Res. 2000;15:1603–1614
  16. Wuster C, de Terlizzi F, Becker S, Cadossi M, Cadossi R, Müller R. Usefulness of quantitative ultrasound in evaluating structural and mechanical properties of bone: Comparison of ultrasound, dual-energy X-ray absorptiometry, micro-computed tomography, and mechanical testing of human phalanges in vitro. Technol Health Care. 2005;13:1–14

PII: S0301-5629(07)00111-1

doi: 10.1016/j.ultrasmedbio.2007.02.018

Ultrasound in Medicine and Biology
Volume 33, Issue 8 , Pages 1184-1190 , August 2007

Article Tools

* Image Usage & Resolution